{"a":[{"_":"Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas","$":{"href":"/pharma/biopharma-saw-q2-sales-boom-led-lilly-sanofi-regeneron-and-astellas","hreflang":"en"}}]}

Summary

Biopharma sector reported strong Q2 earnings with nine of the top 25 drugmakers achieving double-digit revenue increases, led by Eli Lilly with a 48% sales gain. More than half of the top 25 drugmakers realized double-digit sequential gains from Q1 to Q2.